Product Portfolio Updates

Medtronic is dedicated to driving innovation in diabetes management technologies so your patients can focus more on their lives and less on diabetes. Following two recent product launches, we have decided to streamline our product portfolio with two changes taking place in February 2021.

Child and caregiver.

With the launch of the MiniMedTM 770G pump, we have decided to simplify our insulin pump offering and stop selling the MiniMedTM 670G pump after February 1, 2021. Please be assured we will continue to offer the necessary supplies for your patients currently using the MiniMedTM 670G system, including compatible reservoirs, infusion sets, and transmitters. And we will continue to offer 24-hour Technical Support for all your patients. For anyone using a MiniMedTM 670G system today, we do not expect any change in their experience due to this decision to halt new sales of this pump. Medtronic continues to offer new options for insulin pump therapy. With the MiniMed™ 770G system, your patients can continue to take advantage of SmartGuardTM Auto Mode, with the added benefit of Bluetooth® connectivity.  For more information about the MiniMedTM 770G system, visit the product page or speak with your local Medtronic representative.

We have also recently updated our infusion set offering with the launch of the MiniMedTM MioTM Advance infusion set. With this new product already demonstrating an increase in patient satisfaction, we have decided to phase out the previous version, the MiniMedTM MioTM infusion set. After February 1, 2021, this product will no longer be available for purchase. We are committed to continue supporting your patients and ensuring this is a smooth transition. To learn more about the new MiniMedTM MioTM Advance infusion set, along with our full infusion set product offering, visit the product page or speak with your local Medtronic representative.

< Return to Diabetes Digest